Latest news articles
Added 3 days ago Drug news
Mylan and Biocon launch Ogivri in the US, being the first biosimilar trastuzumab approved by the FDA.
Mylan N.V. and Biocon Ltd. announced the U.S. launch of Ogivri (trastuzumab-dkst), a biosimilar to Herceptin (trastuzumab). Ogivri is available...
Added 27 days ago Drug news
Phase III JAVELIN Gastric 100 study of Bavencio fails to meet endpoint in gastroesophageal junction (GEJ) cancer.- Merck/Pfizer
Merck and Pfizer Inc. announced topline results of the Phase III JAVELIN Gastric 100 study evaluating Bavencio (avelumab) as first-line...
Added 2 months ago Drug news
Deciphera Pharmaceuticals announces positive results from INVICTUS pivotal phase III study of ripretinib in patients with advanced gastrointestinal stromal tumors.-
Deciphera Pharmaceuticals, Inc. announced the late-breaking presentation of results from the INVICTUS pivotal Phase III clinical study of ripretinib in...
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Transplantation
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Fibrinogen Deficiency in Bleeding
Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.
Inflammatory Bowel Disease Knowledge Centre
The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.
Inflammatory bowel disease assessment tools
'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.
Fluid Management
Are you up-to-date with the latest evidence of effective procedures for fluid management?
+ 2 more
Hereditary ATTR amyloidosis
Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.
Guidelines
Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...
Added 6 years ago
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Neuroendocrine gastroenteropancreatic tumors (GEP-NETs) constitute a heterogeneous group of tumors with their origin in neuroendocrine cells of the embryological gut. This guideline focuses on diagnosis and pathology/molecular biology...
Added 7 years ago
BSG guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
Over the past few years, there have been advances in the management of neuroendocrine tumours, which have included clearer characterisation, more specific and therapeutically relevant diagnosis, and improved treatments.
Added 7 years ago
Journal articles
Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients.
The aim of this retrospective study was to determine the frequency and timing of trastuzumab cardiotoxicity and its risk factors in real-world setting.
Added 1 year ago
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.
Background: Limited real-world research has investigated ramucirumab for the treatment of patients with gastric or gastroesophageal junction (GEJ) cancer.
Added 1 year ago
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study.
Objective: The RAMoss study aimed to evaluate the safety and efficacy profile of ramucirumab in the "real-life setting".
Added 1 year ago
Clinical trials
Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study (ERASG1)
This study is aimed to evaluate the safety of applying enhanced recovery after surgery for gastric cancer.
Added 2 years ago
Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer.
Added 1 year ago
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer (RAINFALL)
The main purpose of this study is to evaluate the effectiveness of ramucirumab, which is a targeted antibody, in combination with capecitabine and cisplatin compared to capecitabine and cisplatin alone in participants with stomach cancer.
Added 1 year ago
Fiona Holland
Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more
What to say and do when someone has cancer
Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.